Login to Your Account



Washington Roundup

Several Drug-Related Bills Likely to Die with 112th Congress

By Mari Serebrov
Washington Editor

Friday, August 31, 2012
As the House and Senate limp toward their lame duck session with a slate full of tax cut, budget and sequestration issues, it's likely that a number of drug-related bills still sitting in committee will die with the 112th Congress.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription